Allarity Therapeutics Inc【ALLR】株式ニュース

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

Form 8-K - Current report

Allarity Therapeutics Announces Phase 2 Trial of Stenoparib in Combination with Temozolomide for Recurrent Small Cell Lung Cancer Fully Funded by the US Veterans Administration

Trial to explore novel combination therapy for patients with recurrent Small Cell Lung Cancer who have failed...

Form 8-K - Current report

Allarity Therapeutics Announces Board Authorization of $5 Million Share Repurchase Program

Boston (March 3, 2025)—Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2...

Form 8-K - Current report

Allarity Therapeutics Announces Dismissal of Securities Class Action Lawsuit

Boston (February 26, 2025)—Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2...

Form 8-K - Current report

Allarity Therapeutics to Begin Enrollment for New Phase 2 Protocol to Advance Stenoparib Toward FDA Approval in Advanced Ovarian Cancer Patients

Patient enrollment set to begin at leading U.S. clinical trial sites, new drug product already deliveredTrial...

Form 8-K - Current report

Allarity Therapeutics Announces Expansion of Phase 2 Clinical Trial to Accelerate Development of Stenoparib in Advanced Ovarian Cancer

Boston (February 6, 2025)—Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2...

👍️0

Golden Cross 18時間前

Monster news yesterday!!!

$ALLR

👍️ 1 👎️ 1 💎 1 💯 1 🤢 1 ⭐️ 1

Golden Cross 2日前

$ALLR Allarity Therapeutics Announces Phase 2 Trial of Stenoparib in Combination with Temozolomide for Recurrent Small Cell Lung Cancer Fully Funded by the US Veterans Administration
https://finance.yahoo.com/news/allarity-therapeutics-announces-phase-2-130000563.html

ALLR...96...Added here...🥳

georgie18

Member Level
Re: georgie18 post# 675910

Tuesday, March 04, 2025 7:48:48 AM

Post#
676027
of 676179
ALLR...92...🥳...Hit $1.01...

georgie18

Member Level
Re: georgie18 post# 390813

Monday, March 03, 2025 9:50:54 AM

Post#
390818
of 390832
ALLR...9455...🥳

georgie18

Member Level
Re: georgie18 post# 675278

Monday, March 03, 2025 8:07:22 AM

Post#
675893
of 675909
ALLR...88...🥳...5 Million dollar board approved repurchase program...announced this morning...

georgie18

Member Level
Re: georgie18 post# 390587

Monday, February 24, 2025 10:52:12 AM

Post#
390694
of 390812
ALLR...79...Added the dip...🥳... https://www.globenewswire.com/news-release/2025/02/24/3031065/0/en/Allarity-Therapeutics-to-Begin-Enrollment-for-New-Phase-2-Protocol-to-Advance-Stenoparib-Toward-FDA-Approval-in-Advanced-Ovarian-Cancer-Patients.html

georgie18

Member Level
Re: georgie18 post# 674892

Friday, February 21, 2025 9:36:04 AM

Post#
675048
of 675277
ALLR...97s clearing here...🥳...Off the .90 range bottom...

georgie18

Member Level
Re: georgie18 post# 389759

Thursday, February 20, 2025 10:06:24 AM

Post#
390508
of 390586
ALLR...Loading .90s...🥳...averaging down...$1.03

georgie18

Member Level
Re: georgie18 post# 673394

Thursday, February 06, 2025 8:08:38 AM

Post#
673498
of 674891
ALLR...$1.23...🥳... https://www.globenewswire.com/news-release/2025/02/06/3021970/0/en/Allarity-Therapeutics-Announces-Expansion-of-Phase-2-Clinical-Trial-to-Accelerate-Development-of-Stenoparib-in-Advanced-Ovarian-Cancer.html

👍️0

stocktowatch 4日前

$ALLR Allarity Therapeutics (ALLR): A Biotech Turnaround With FDA Fast-Track Potential
https://docs.google.com/document/d/18xKdntXBscs8Qpbx3DUZJCPhEPuLPOly3G1UonXYNeo/mobilebasic

👍️0

georgie18 4日前

ALLR...92...🥳...Hit $1.01...

georgie18

Member Level
Re: georgie18 post# 390813

Monday, March 03, 2025 9:50:54 AM

Post#
390818
of 390832
ALLR...9455...🥳

georgie18

Member Level
Re: georgie18 post# 675278

Monday, March 03, 2025 8:07:22 AM

Post#
675893
of 675909
ALLR...88...🥳...5 Million dollar board approved repurchase program...announced this morning...

georgie18

Member Level
Re: georgie18 post# 390587

Monday, February 24, 2025 10:52:12 AM

Post#
390694
of 390812
ALLR...79...Added the dip...🥳... https://www.globenewswire.com/news-release/2025/02/24/3031065/0/en/Allarity-Therapeutics-to-Begin-Enrollment-for-New-Phase-2-Protocol-to-Advance-Stenoparib-Toward-FDA-Approval-in-Advanced-Ovarian-Cancer-Patients.html

georgie18

Member Level
Re: georgie18 post# 674892

Friday, February 21, 2025 9:36:04 AM

Post#
675048
of 675277
ALLR...97s clearing here...🥳...Off the .90 range bottom...

georgie18

Member Level
Re: georgie18 post# 389759

Thursday, February 20, 2025 10:06:24 AM

Post#
390508
of 390586
ALLR...Loading .90s...🥳...averaging down...$1.03

georgie18

Member Level
Re: georgie18 post# 673394

Thursday, February 06, 2025 8:08:38 AM

Post#
673498
of 674891
ALLR...$1.23...🥳... https://www.globenewswire.com/news-release/2025/02/06/3021970/0/en/Allarity-Therapeutics-Announces-Expansion-of-Phase-2-Clinical-Trial-to-Accelerate-Development-of-Stenoparib-in-Advanced-Ovarian-Cancer.html

👍️0

glenn1919 5日前

ALLR.................................https://stockcharts.com/h-sc/ui?s=ALLR&p=W&b=5&g=0&id=p86431144783

👍️0

georgie18 5日前

ALLR...9455...🥳

georgie18

Member Level
Re: georgie18 post# 675278

Monday, March 03, 2025 8:07:22 AM

Post#
675893
of 675909
ALLR...88...🥳...5 Million dollar board approved repurchase program...announced this morning...

georgie18

Member Level
Re: georgie18 post# 390587

Monday, February 24, 2025 10:52:12 AM

Post#
390694
of 390812
ALLR...79...Added the dip...🥳... https://www.globenewswire.com/news-release/2025/02/24/3031065/0/en/Allarity-Therapeutics-to-Begin-Enrollment-for-New-Phase-2-Protocol-to-Advance-Stenoparib-Toward-FDA-Approval-in-Advanced-Ovarian-Cancer-Patients.html

georgie18

Member Level
Re: georgie18 post# 674892

Friday, February 21, 2025 9:36:04 AM

Post#
675048
of 675277
ALLR...97s clearing here...🥳...Off the .90 range bottom...

georgie18

Member Level
Re: georgie18 post# 389759

Thursday, February 20, 2025 10:06:24 AM

Post#
390508
of 390586
ALLR...Loading .90s...🥳...averaging down...$1.03

georgie18

Member Level
Re: georgie18 post# 673394

Thursday, February 06, 2025 8:08:38 AM

Post#
673498
of 674891
ALLR...$1.23...🥳... https://www.globenewswire.com/news-release/2025/02/06/3021970/0/en/Allarity-Therapeutics-Announces-Expansion-of-Phase-2-Clinical-Trial-to-Accelerate-Development-of-Stenoparib-in-Advanced-Ovarian-Cancer.html

👍️0

georgie18 5日前

ALLR...88...🥳...5 Million dollar board approved repurchase program...announced this morning...

georgie18

Member Level
Re: georgie18 post# 390587

Monday, February 24, 2025 10:52:12 AM

Post#
390694
of 390812
ALLR...79...Added the dip...🥳... https://www.globenewswire.com/news-release/2025/02/24/3031065/0/en/Allarity-Therapeutics-to-Begin-Enrollment-for-New-Phase-2-Protocol-to-Advance-Stenoparib-Toward-FDA-Approval-in-Advanced-Ovarian-Cancer-Patients.html

georgie18

Member Level
Re: georgie18 post# 674892

Friday, February 21, 2025 9:36:04 AM

Post#
675048
of 675277
ALLR...97s clearing here...🥳...Off the .90 range bottom...

georgie18

Member Level
Re: georgie18 post# 389759

Thursday, February 20, 2025 10:06:24 AM

Post#
390508
of 390586
ALLR...Loading .90s...🥳...averaging down...$1.03

georgie18

Member Level
Re: georgie18 post# 673394

Thursday, February 06, 2025 8:08:38 AM

Post#
673498
of 674891
ALLR...$1.23...🥳... https://www.globenewswire.com/news-release/2025/02/06/3021970/0/en/Allarity-Therapeutics-Announces-Expansion-of-Phase-2-Clinical-Trial-to-Accelerate-Development-of-Stenoparib-in-Advanced-Ovarian-Cancer.html

👍️0

Millenium323 1週前

ALLR could be trading at $4.00 based on its cash alone. It currently has a sub $4 million dollar market cap. According to yesterdays press release, "Allarity expects to pursue multiple advantaged regulatory pathways to expedite approval in the first half of 2025. Allarity will also be presenting key data, with abstracts now accepted, at multiple upcoming scientific and clinical conferences." I expect this to be trading much higher in the very near future. The current price and market cap make little sense and are artificially low especially for a cancer stock with a drug showing promise in Phase 2.

https://finance.yahoo.com/news/allarity-therapeutics-begin-enrollment-phase-130000704.html

👍️0

Acehole 2週前

Just another pharma scam company. CEO Thomas "Jackass" Jenson is collecting nearly $50k/month salary while he defrauds investors. The company needs $30 Million to do their trial. They have perhaps $15 Million cash on hand right now with a monthly burn rate of about $500k. There are ZERO institutional investors. Jackass Jenson is going to dilute shareholders into oblivion for the rest of the year. There is no chance they stay listed on Nasdaq. Do NOT invest a penny here.

👍️0

Monksdream 2週前

ALLR, new 52 week low

👍️0

MC10459 2週前

This was at $250 pps a year ago. This thing dropped like a rock. Someone tell me why those days aren't long gone.

👍️0

georgie18 2週前

ALLR...79...Added the dip...🥳... https://www.globenewswire.com/news-release/2025/02/24/3031065/0/en/Allarity-Therapeutics-to-Begin-Enrollment-for-New-Phase-2-Protocol-to-Advance-Stenoparib-Toward-FDA-Approval-in-Advanced-Ovarian-Cancer-Patients.html

georgie18

Member Level
Re: georgie18 post# 674892

Friday, February 21, 2025 9:36:04 AM

Post#
675048
of 675277
ALLR...97s clearing here...🥳...Off the .90 range bottom...

georgie18

Member Level
Re: georgie18 post# 389759

Thursday, February 20, 2025 10:06:24 AM

Post#
390508
of 390586
ALLR...Loading .90s...🥳...averaging down...$1.03

georgie18

Member Level
Re: georgie18 post# 673394

Thursday, February 06, 2025 8:08:38 AM

Post#
673498
of 674891
ALLR...$1.23...🥳... https://www.globenewswire.com/news-release/2025/02/06/3021970/0/en/Allarity-Therapeutics-Announces-Expansion-of-Phase-2-Clinical-Trial-to-Accelerate-Development-of-Stenoparib-in-Advanced-Ovarian-Cancer.html

👍️0

omda 2週前

Hey to all, When the clinical trials are concluded with the stenoparib will this get an FDA approved?

👍️0

georgie18 2週前

ALLR...97s clearing here...🥳...Off the .90 range bottom...

georgie18

Member Level
Re: georgie18 post# 389759

Thursday, February 20, 2025 10:06:24 AM

Post#
390508
of 390586
ALLR...Loading .90s...🥳...averaging down...$1.03

georgie18

Member Level
Re: georgie18 post# 673394

Thursday, February 06, 2025 8:08:38 AM

Post#
673498
of 674891
ALLR...$1.23...🥳... https://www.globenewswire.com/news-release/2025/02/06/3021970/0/en/Allarity-Therapeutics-Announces-Expansion-of-Phase-2-Clinical-Trial-to-Accelerate-Development-of-Stenoparib-in-Advanced-Ovarian-Cancer.html

👍️0

georgie18 2週前

ALLR...Loading .90s...🥳...averaging down...$1.03

georgie18

Member Level
Re: georgie18 post# 673394

Thursday, February 06, 2025 8:08:38 AM

Post#
673498
of 674891
ALLR...$1.23...🥳... https://www.globenewswire.com/news-release/2025/02/06/3021970/0/en/Allarity-Therapeutics-Announces-Expansion-of-Phase-2-Clinical-Trial-to-Accelerate-Development-of-Stenoparib-in-Advanced-Ovarian-Cancer.html

👍️0

stocktowatch 3週前

$ALLR An in-depth review of Allarity’s maturing clinical data, in collaboration with leading clinical investigators, prompted Allarity to design this new Phase 2 protocol to enable a more aggressive push of stenoparib toward regulatory approval. The protocol will enable new enrollment expressly focusing on patients with advanced, recurrent, platinum-resistant disease, a group that has shown durable clinical benefit from stenoparib in the current phase 2 trial and who have only limited treatment options following standard chemotherapy. In addition to expanding and deepening the clinical data set necessary for regulatory approval, this trial is also designed to enhance the understanding of stenoparib’s unique therapeutic mechanism of action. Of particular interest will be the impact of stenoparib treatment on the Wnt pathway, a key cellular pathway repeatedly shown to be involved in advanced ovarian cancers as well as many other advanced cancer types, most notably colon cancers. A richer understanding of stenoparib’s potential for controlling the Wnt pathway—a key aspect of the newly designed trial—could further distinguish stenoparib as a unique investigational cancer treatment.

👍️0

stocktowatch 4週前

$ALLR News - Allarity Therapeutics Announces Expansion of Phase 2 Clinical Trial to Accelerate Development of Stenoparib in Advanced Ovarian Cancer
https://finance.yahoo.com/news/allarity-therapeutics-announces-expansion-phase-130000934.html

👍️ 1

georgie18 4週前

ALLR...$1.23...🥳... https://www.globenewswire.com/news-release/2025/02/06/3021970/0/en/Allarity-Therapeutics-Announces-Expansion-of-Phase-2-Clinical-Trial-to-Accelerate-Development-of-Stenoparib-in-Advanced-Ovarian-Cancer.html

👍️0

georgie18 1月前

ALLR...$1.15...Trying to turn up here...🥳

👍️0

omda 1月前

What's happening to this company, will it become bankrupt and permanently delisted. I gave it a thumbs up for cancer research. Was fraud detected in the company financials report or maybe the clinic trials have failed. Any comments on this?

👍️0

georgie18 1月前

ALLR...$1.19...Reversing off the $1 LOD...🥳

👍️0

koolmc 1月前

1.20s from 1 dip, get it past 1.30's again chance for bigger move imo

👍️0

stocktowatch 1月前

$ALLR Allarity Therapeutics (ALLR): A Biotech Turnaround With FDA Fast-Track Potential

1. The Troubled Past: Poor Leadership and Financial Mismanagement
Allarity Therapeutics was once plagued by severe financial mismanagement, regulatory concerns, and questionable leadership. The company faced Wells Notices, an SEC investigation, and disastrous financing decisions, leaving investors uncertain about its future.

Key Issues Under Previous Leadership:
? Wells Notices & SEC Investigation: The company was under regulatory scrutiny for past financial decisions. (Source)

? Dilutive Financing: Multiple rounds of toxic financing and poor capital structure decisions led to massive shareholder dilution. (Source)

? Stock Price Collapse & Nasdaq Compliance Issues: Due to financial mismanagement, the company faced delisting threats from Nasdaq. (Source)

👍️0

luckydude777 1月前

If I was a Market Maker, I would do to this stock what has been DONE to it this last week. Attempt to break the confidence of everyone connected with the company so cheaper shares could be accumulated.

CHEAPER SHARES?!!!!!!!!!!!!!!!!!!!

Sure. Market Makers KNOW that companies like ATTR who are devoting their time and talent to helping cure people of cancerous issues are WORTH far more than any AI stock you can buy right now.

Watch disgruntled AI chip investors TURN to a sector that is trying to extend the quality of life for humanity. ALLR fits the bill for me.

👍️0

koolmc 1月前

peeps were expecting news yesterday besides the settlement

👍️0

Millenium323 1月前

$ALLR only has a market cap of around $6 million with a drug in Phase 2 clinical trials. It should be trading at $20 per share right now. Oh well it looks like I will be adding. No one ever said the stock market was efficient.

👍️0

georgie18 1月前

ALLR...$1.23...Bouncing off the $1.12 dip...🥳

👍️0

LonesomeGeorge 1月前

Well, this is fantastic.

👍️0

koolmc 1月前

grabbed some 1.17's on dip heading into the data release.

ALLR...$1.36...🥳 ... https://www.globenewswire.com/news-release/2025/01/30/3017967/0/en/Allarity-Therapeutics-Announces-Filing-of-Form-8-K-Regarding-Settlement-Agreement-in-Principle-with-SEC.html

👍️0

15for2 1月前

looked like a low volume stop-loss sweep, imo
could get really interesting this afternoon
$ALLR

RNAZ flying today with little more than speculation. Has more shares outstanding than ALLR and no assurance it has medicine any better than ALLR's ... far as anyone is sharing right now.

I'm looking for ALLR to start climbing near the close today and maybe higher in A/H.s. Tomorrow morning should get a lot of generous upside going into the mid-afternoon if all goes well.

👍️0

luckydude777 1月前

Added to the treasure chest some of those $1.49's.

👍️0

luckydude777 1月前

$ALLR presenting tomorrow approx 2:15 pm
Fasten your seatbelts

👍️0

boston127 1月前

I need toi follow your alerts.

Good call.

👍️0

Law of Averages 1月前

Maybe we might test next resistance level at $2.25

👍️0

georgie18 1月前

Ruff Ruff...🥳...Hit $1.99 of my $1 Alert...

👍️0

koolmc 1月前

nice little pop riding the rest after taking profits gl

👍️0

georgie18 1月前

Their all dogs until their not... Well I bought this dog at $1 and it hit $1.72...🥳...

👍️ 1 💯 1

boston127 1月前

ALLR is a dog.

company has great products, still being tested, but has no value. It is worth minus $11M. Looks like a P&D.

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター